Skip to main content
. 2022 Sep 18;27(18):6087. doi: 10.3390/molecules27186087

Figure 10.

Figure 10

The PLI profile of the most potent analogue (21): (A) analogue 21 against acetylcholinesterase (AChE); (B) analogue 21 against butyrylcholinesterase (BuChE) enzymes.